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Abstract
Otitis Media is defined as inflammation of the middle ear region associated with middle ear
fluid. This condition typically follows an upper respiratory infection, is commonly misdiagnosed
by physicians and can potentially lead to the inappropriate use of antimicrobial agents. [1] This
thesis describes the design of a novel medical device that utilized spectroscopy and digital
imaging to provide physicians with a unique representation of the middle ear. Published
literature has been reviewed to assess the different approaches that researchers have studied to
improve the diagnosis of otitis media, where, for example, research conducted by Thorton et al.
and Boppart et al. used fluorescence to identify bacteria contained in biofilms.[12,13] In addition, a
population study conducted by Jensen et al. determined what the level of diagnostic certainty is
in pediatric patients and determined that general practitioners had a diagnostic certainty of 58%
in patients under one year of age and 73% certainty in patients over two and a half years of
age.[9]
Eleven subjects, each with a history of recurrent acute otitis media and requiring
myringotomy and ear tube placement, were selected for study in this thesis. All subjects received
a digital imaging and spectroscopy examination using the device at the time of surgery. Five
excitation and illumination wavelengths were used, including white light, 385-420 nm, 450-470
nm, 520-535 nm, and 640-650 nm as well as fluorescence imaging using 425 nm and 450 nm
filters. Each of the chosen wavelengths were emitted into the ear canal and tympanic membrane
during a typical otoscopic examination. Signal processing techniques were also applied to isolate
various regions of the tympanic membrane using MatLAB to increase the resolution of the
anatomical and physiological properties of the tympanic membrane.

x

The spectral readings between the wavelengths of 560 nm and 760 nm were plotted for each
subject and were classified according to fluid retention, consistency, and vascularity. In this
subject population, eight of the 22 ears were identified to be a noneffusion normal. Reflectance
of keratin, cerumen, and bone, with well defined blood vessels and contrast, allowed for better
characterization of the middle ear. [8] Reflectance spectra were classified according to fluid
consistency and trends were determined for non effusion and effusion patients. Class one spectra
were defined as tympanic membrane and canal spectra with a rapid increase in percent reflection
between 575 nm and 650 nm and a rapid decrease in percent reflection between 650 nm and 750
nm. Class two spectra were defined as tympanic membrane and canal spectra with a gradual
decrease in percent reflection between 575 nm and 800 nm. This novel device was successfully
used to detect effusion consistency and color and it will continue to aid in the development of a
new diagnostic procedure. It provides a means for the creation of a new diagnostic procedure that
may be useful in assisting a physician in making an accurate diagnosis, and as a result, increase
the diagnostic certainty.

xi

1.0 Introduction
Otitis Media is characterized by the presence of fluid in the middle ear often following an
upper respiratory infection and commonly affects infants and toddlers between ten months and
four years of age. Physicians and ear, nose, and throat (ENT) specialists consistently
misdiagnose otitis media, potentially leading to the inappropriate use of microbial agents which
could hinder the well-being of the child .[1] Studies show that Acute Otitis Media resulted in 8.8
million cases; costing $2.8 billion on health care costs, $1.8 billion on ambulatory visits, and $.4
billion on over the counter prescriptions in 2006. [2] The number of acute otitis media cases
justifies development of a method capable of assisting physicians to determine the diagnosis with
increased diagnostic certainty. A new diagnostic method to facilitate in the diagnosis of otitis
media in pediatric patients is presented to provide physicians with a tool that will assist otitis
media diagnosis.
Red and swollen tympanic membranes are not the only characteristics of infection that
should be considered for diagnosis of otitis media. The novel design of an otoscope presented in
this thesis entailed the design of a device that utilized spectroscopy and fluorescence imaging to
provide physicians with a tool that uniquely represents the middle ear to enhance the infection’s
characteristics. The enhanced characteristics of the tympanic membrane could potentially allow
the user to determine whether or not there is infected fluid present which requires antibiotics due
to the fluorescence and spectroscopy functions of the otoscope design.
There are three types of otitis media that are typically diagnosed in the pediatric population.
Acute otitis media (AOM) is a condition that is characterized by inflammation of the middle ear
and diagnosed after an upper respiratory infection or fever. Acute otitis media is characterized by
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infected fluid behind the tympanic membrane and is commonly associated with otalgia, otorrhea,
headache, and vomiting. Otitis media with effusion (OME) often follows a case of acute otitis
media and is associated with sterile fluid retained in the middle ear region. [5] This type of otitis
media is very hard to diagnose and is often mis diagnosed by practitioners due to the lack of
acute symptoms. Otitis media with effusion can also lead to hearing loss, tinnitus, vertigo, and
otalgia. [5] The fluid retained in the middle ear region may drain on its own over the course of a
few weeks but will result in conductive hearing loss if the condition continued. [5]
Acute otitis media can benefit from the prescription of antibiotics; however, antibiotic
treatment is not indicated for otitis media with effusion. Physicians must be capable of
distinguishing between acute otitis media and otitis media with effusion because each condition
does not have the same treatment when diagnosed correctly. General practitioners may diagnose
a red, swollen tympanic membrane as otitis media; however, the determination of infected or non
infected fluid is required to confirm the specific diagnosis. A whiteish-yellow bulging tympanic
membrane is generally observed with acute otitis media due to the presence of pus and is more
frequently correctly diagnosed by physicians.
The anatomical structure of the middle ear and Eustachian tube provides insight as to
why otitis media is most commonly found in pediatric patients rather than an older population.
The Eustachian tube is horizontally positioned allowing for inadequate pressure equalization and
possible fluid retention in the middle ear during the first years of life. An initial respiratory
infection and disruption of the Eustachian tube may lead to fluid retention due to the horizontal
position. A swollen Eustachian tube may act as a suction to retain viral or bacterial fluid in the
middle ear space when an effusion is present. The Eustachian tube will mature to a vertical
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position to allow for better pressure equalization and fluid drainage as a child’s internal anatomy
matures.

Figure 1: Comparison of an Infant and Adult Eustachian Tube [6]

Patients that have recurrent acute otitis media or persistent OME affecting speech or hearing
loss receive a myringotomy and tubes. The myringotomy and tubes procedure is completed for
pressure equalization and fluid drainage in the middle ear region. The procedure begins with the
insertion of an ear tube through an incision in the tympanic membrane as in Figure 2. The ear
tube will allow air to enter the middle ear region and subsequently prevent additional fluid from
accumulating. The ear tubes fall out after approximately six to twelve months. [7]

a)

b)

Figure 2: (a) Tympanic membrane before insertion is made (b) Tympanic membrane after ear tube insertion

An otoscope primarily consists of a head, handle, magnifying lens and a light source. A
plastic interchangeable speculum is attached to the tip of the otoscope for insertion into the
3

auditory canal as in Figure 3. The otoscope is used by pulling on the pinna to subsequently
straighten the ear canal for direct insertion into the ear. The physician can observe the middle ear
through a magnifying lens. The interpretation of the findings in the middle ear with an otoscope
is dependent on the experience of the physician at the time of diagnosis and has proven to often
lack diagnostic certainty. This may lead to the wrongful prescription of antibiotics to the patient.

Figure 3: Otoscope inserted into the ear canal [3]

Many modern otoscopes also include an optical system that is more complex than a traditional
otoscope and result in a better field of view, magnification and manual focus of the lens for
patients with various ear canal lengths and for users with nearsightedness. [4]

The development of the otoscope described in this paper for fluorescence and digital imaging
was developed to explore the possibility of distinguishing between acute otitis media and otitis
media with effusion and subsequently increase the reliability of an accurate diagnosis. Various
bones and regions behind the tympanic membrane were visualized with the otoscope’s varying
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wavelengths of light. The differences between ears with an effusion and non effusion were also
investigated for the same purpose. The combination of spectroscopy with digital imaging was
investigated to determine whether there were spectral differences between different wavelengths.
Specifically, the spectral graphs demonstrated the light reflected or absorbed from a fluid as a
function of the associated wavelength. Signal processing techniques were also applied to isolate
various regions of the tympanic membrane using MatLab to increase the resolution of the
anatomical and physiological properties of the tympanic membrane. Furthermore, the signal
processing techniques were investigated to compare the recorded images and spectra for each
patient. The design was more effective than a traditional otoscopy due to the reflectance of
keratin, ceruem and bone with well-defined blood vessels and contrast visualized between the
malleus and the rest of the tympanic membrane. [8] The newly developed otoscope, along with
digital or fluorescence imaging, and spectroscopy had the potential to be an effective approach to
diagnose pediatric patients with otitis media with increased diagnostic certainty.

1.1. Background
A study performed by Jensen et al. was conducted to determine what the acute otitis media
diagnostic certainty was in pediatric patients. [9] The study determined that general practitioners
were certain of the diagnosis in patients less than one year of age 58% of the time. It was also
determined that there was a 73% certainty in patients over two and a half years of age. The
diagnostic uncertainty was influenced by the diagnostic equipment, diagnostic criteria, the
general practitioners knowledge, the presence of cerumen, and the behavior of the child. [9]
Similar studies have been completed to differentiate between acute otitis media and otitis
media with effusion. One of the main reasons for carrying out this study was that the certainty of
a diagnosis by primary care physicians in patients under the age of 0 to12 months was 58%, 66%
5

in children 13 to 30 months and 73.3% in children over 30 months. [10] There were two hundred
and fifty eight patients that were categorized with acute otitis media, otitis media with effusion,
and normal ears. The study required a skilled physician to examine each patient with an otoscope
and diagnose them as either having acute otitis media, chronic otitis media, or a normal ear. The
otoscope for the experiment incorporated an optical fiber and spectrometer. The diagnoses for
each patient according to the physician and the raw spectra were compared and demonstrated
that a skilled physician is capable of frequent misdiagnoses, resulting in unnecessary
prescriptions to patients. This study has also proven that an otoscope that uses a spectroscopic
method can quickly and noninvasively determine whether an individual has Otitis Media.
Armengol et al. performed a study to determine how often acute otitis media occurred in
pediatric patients between six months and three years of age. [11] The patients were asked to
return to their pediatrician for photographic and tympanometry readings of the ear before a cold
and six to ten times during the cold. They determined that acute otitis media occurred in 55% of
the colds, in 100% of patients with preexisting middle ear effusions, and in 5% of colds with no
preexisting middle ear effusions. The investigators were able to determine that acute otitis media
is a direct effect of the common cold in children, especially in cases when the children were
previously diagnosed with middle ear effusions.
Research has been performed to determine what classifications of bacteria involved in
acute otitis media do not respond to antibiotics. Thorton et al. investigated the effects of biofilm
on otitis media diagnostics and determined that certain active bacteria that are unable to be
cultured and are eradicated by antibiotic treatment are present in otitis media. [12] A biofilm is a
colony of bacteria that forms on tissues to protect various bacteria from responding to antibiotics.
This study aimed to determine whether the presence of a biofilm or intracellular bacteria may
6

play a role in the in-effectiveness of current treatments that are used for acute otitis media. The
identification of the bacterium embodied in biofilm may determine the diagnosis of otitis media
and the appropriate antibiotic prescription. Twenty patients that underwent surgery were
recruited in the study. Each of these patients received a mucosal ear biopsy to determine whether
pathogenic bacteria was contained intracellular or in a bacteria culture of biofilm.[12] A
transmission electron microscope, and species fluorescent in situ hybridization and a confocal
scanning microscope were used to complete the observations. The FISH technique was earlier
developed to track DNA sequences on chromosomes.[12] In this case, it was used to determine the
DNA sequences on middle ear mucosa to identify the presence of specific bacteria. The
transmission electron microscope allowed the determination of the presence of intracellular
bacteria and within cells; however the investigators were unable to identify the classification of
the bacteria. The FISH and confocal scanning microscope allowed the determination of bacteria
in fifteen of the total seventeen biopsies. Additionally, biofilm was observed in eleven biopsies
and twelve were determined to have intracellular bacteria. [12] The use of the FISH technique and
confocal scanning microscope enabled the investigators to determine a distinctive pattern
between the DNA and associated bacteria involved with the reoccurring diagnosis of otitis
media.
Boppart et al. studied the effects of biofilms on otitis media diagnosis and stated that
“biofilms are thick adherent, glue-like material formed by polymicrobial communities of bacteria
that act as protective microenvironments where bacteria can reside and colonize”. [13] The
findings that the bacteria formed in biofilms were resistant to antibiotics led to increased
administration of antibiotics to children. They also studied the use of optical coherence
tomography on otitis media biofilms using near infrared light. The researchers determined that
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the noninvasive use of near infrared light has been known to capture ten to one hundred times
better resolution than ultrasound waves noninvasively for otitis media biofilms. An otoscope
with an optical coherence tomography scanner capable of providing optical coherence
tomography images for visual representation on a laptop was presented in this paper as well.
Previous research has identified different techniques to facilitate the diagnosis of otitis
media. Spector et al. investigated the noninvasive fluorescent identification of bacteria using
fluorescence spectroscopy.[14] A mechanism of determining the type of bacteria using
fluorescence spectroscopy was determined by identifying Streptococcus pneumoniae,
Haemophilus influenzae, and Staphylococcus aureus using excitation wavelengths on the
tympanic membrane. Sundberg et al. determined that the use of reflectance spectroscopy defined
differences in effusion fluid in pediatric patients. [15] They also determined that otitis media with
serous effusion was distinguished from otitis media with mucous effusion. Further research by
Van der Jeught et al. has studied the thickness of the tympanic membrane, to create threedimensional surface generation using optical coherence tomography. [16] The average thickness
of the tympanic membrane was determined across various regions with similar regions of
increased thickness. The reflectance and fluorescence spectroscopy methods and the average
thickness of the tympanic membrane will be used in this study to facilitate the diagnosis of otitis
media.

1.2. Commercial Products
Different commercial products currently used in the ear nose and throat industry are
presented. Each of the devices described were presented because they contribute traditional
technology as well as functionality new to the field. Typical otoscopes, such as the Welch Allen
Macroview otoscope, were described due to its ability to record video in real time. Devices that
8

have recently been developed, such as the Cellscope otoscope, were included to provide an
example of the recent technological advances in the ear, nose and throat industry.
The Welch Allen Digital Macroview otoscope is a commercial otoscope capable of providing
digital recorded images in a medical setting. The device allows the physician to visualize a clear
view of the tympanic membrane in the office which allows for additional communication
between the patient and the physician. The otoscope enables the physician to save the images to
a patient’s file and to serve as an educational reference as in Figure 4. This tool can also be used
as an educational training aid as high resolution images can be visualized from a laptop.
Additionally, the high resolution of the camera also allows for the distinction between objects of
very fine detail.

Figure 4: Welch Allen Digital Macroview otoscope

[17]

Various video otoscopes are currently sold commercially for use in a medical environment.
The Aurical OTOcam 300 video otoscope combines the traditional otoscope with high power
light sources and OTOsuite software to enhance the characteristics of otitis media and to improve
the diagnosis.

[18]

Additionally, the firefly DE550 handheld digital wireless video otoscope has
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been developed with additional components that are not incorporated on traditional otoscopes.
The firefly otoscope in Figure 5 features wireless connectivity to a laptop with variable
magnification between fifteen and one hundred and fifty times digitally. The otoscope operates
in real time with thirty frames per second using firefly pro software. Images are recorded via the
button on the otoscope and can transmit the images to a computer up to thirty feet away. [19]

Figure 5: Firefly wireless otoscope and software demo

[19]

Cellscope otoscope is a commercial device that took a unique and modern approach to otitis
media diagnosis. The cellscope provided a quick mechanism to diagnose an ear infection directly
from an iphone for immediate diagnosis by an untrained or trained individual. The purpose of the
cellscope design as seen in Figure 6, was to provide a high quality diagnosis without taking a trip
to a physician’s office. A speculum attachment and iphone app was all that was required to
record an image of the ear canal, middle ear and tympanic membrane with high resolution and
visibility. A study found on the distributor’s website recruited sixty three patients who visited the
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emergency room between May and December of 2012. The patients were diagnosed with the
Cellscope Oto and a traditional otoscope at the time of the visit. Forty nine of the patients were
diagnosed with acute otitis media and there was no difference in the quality or diagnosis between
the traditional otoscope and the Cellscope Oto when shown to physicians. Parents also felt
comfortable taking additional images at home that would be sent to the physician for continued
diagnostic treatment.

Figure 6: Cellscope otoscope

[20]
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2.0 Methods
An otoscope for fluorescence and digital imaging was developed to increase the reliability of
an accurate diagnosis of otitis media. The combination of spectroscopy with digital imaging was
investigated to determine whether there were spectral differences between different wavelengths
using a multi-wavelength light source. More specifically, reflectance spectroscopy and digital
imaging were performed independently to identify similarities between middle ear fluid
properties and the two procedures were also used to determine whether or not the detection of an
effusion could be non-invasively identified by a physician.
Reflectance spectroscopy was included to identify the light reflected or absorbed from a fluid
as a function of the associated wavelength. Differences in intensity and percent reflection as a
function of wavelength were recorded for the tympanic membrane and canal spectra. A criterion
was developed to differentiate between different spectral properties patients with and without an
effusion as a function of the associated wavelength. Class one was defined as tympanic
membrane and canal spectra with a rapid increase in percent reflection between 575 nm and 650
nm and a rapid decrease in percent reflection between 650 nm and 750 nm. Class two was
defined as tympanic membrane and canal spectra with a gradual decrease in percent reflection
between 575 nm and 800 nm. Class three and four spectra were defined to group spectra that
deviated from the typical waveforms of class one and two.
This otoscope was designed to be used either for surgical procedures or routine patient
visits. Accordingly a disposable spectrum was changed between patients and the otoscope was
disinfected with an alcohol cloth after each patient. Necessary precautions were taken into
account to prevent the spread of bodily fluids and bacteria during the procedure. Electrical safety
precautions needed to be considered to ensure electrical safety. The device was approved by the
12

clinical engineering department at Connecticut Children’s Medical Center and the procedure was
approved by the Institutional Review Board at Connecticut Children’s Medical Center. [4]

2.1. Design
The otoscope design, pictured in Figure 7, included two high power light emitting diodes
(LEDs) intended to illuminate the tympanic membrane. A high power red, green, blue, white
(RGBW 625 nm, 523 nm, 455 nm, white) and high power Ultraviolet (UV 400-405nm) LED
were integrated into the design.

Figure 7: Complete otoscope design

The electrical design in Figure 8 featured an LED constant current source and AC power source
for maximum power and light intensity. The high power LEDs were mounted on thermal heat
sinks designed to hold both LEDs in a stable enclosure using a spring locking mechanism for
maximum efficiency. Five pushbutton switches and a power switch were mounted on a switch
box for easy activation of each excitation wavelength.
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Figure 8: Electrical LED design implemented in the otoscope.

2.1.1. Mechanical Assembly
The otoscope was designed to feature a traditional Welch Allen otoscope head combined
with components useful for Fluorescence and Digital Imaging Analysis of the tympanic
membrane. The aluminum frame was built into three separate pieces including the base, handle,
and heat sink. The base was designed to align the CMOS camera, filter wheel, optical insert and
Welch Allen otoscope head on a center optical axis. Light from the heat sink cavity was directed
into the ear through the Welch Allen otoscope head from the heat sink as pictured in Figure 9.
The excitation and emission wavelengths both reflected off of the tympanic membrane directly
into the otoscope’s optical axis. The filter wheel was designed to pass the emission wavelength
along the axis into the camera to record an image on a laptop through USB.

14

Emission wavelength is initiated in
the Tympanic Membrane.

Figure 9: Mechanical design of the otoscope

The top, bottom and front view of the base of the otoscope in Figures 10 through 12 represented
the 7.222 x 1.8 x 0.726 in. dimensions of the frame.

Figure 10: CAD drawing of the top view of the base of the frame (units in inches)

Figure 11: CAD drawing of the bottom view of the base of the frame (units in inches)

The Welch Allen otoscope head was designed to fit securely into the base of the frame on a 165
degree angle. This was designed to provide a direct optical path from the LEDs to the CMOS
camera.
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Figure 12: CAD drawing of the front view of the base of the frame (units in inches)

2.1.1.1. Optical Insert
An aluminum optical insert was designed to secure the filter wheel into the base of the
frame. This piece filtered light that passed from the filter wheel to the camera through the insert.
A screw was fastened to the optical insert to mate the filter wheel to the bottom of the frame. It
was built out of a block of aluminum and cut to a height of 2.00 in., length of 1.00 in. and width
of 1.8 in. The insert was 0.125 inches thick and sat flush with the base of the frame.
Additionally, the diameter of the filter wheel hole was 0.3940 inches and was designed to sit
1.408 inch from the base of the frame. The mounting screws in Figure 13 were positioned 1.5
inches apart.

a)

b)

c)

d)

Figure 13: CAD drawing of the (a) front (b) back (c) right (d) top view of the optical insert (units in inches)
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2.1.1.2. Heat Sink
The heat sink in Figures 14 through 16 was designed to dissipate heat evenly for
maximum electrical efficiency and measured 2.6 in. x 2.4 in. x 0.8561 inch. It was mounted
directly beneath the Welch Allen Otoscope head and featured two recessed one inch by one inch
compartments to house the LEDs. The LEDs were mounted inside of the heat sink in mounting
holes with M3 #4-40 mounting screws. The component was designed to move in perpendicular
alignment to the otoscope for use of each LED. It was positioned so that the top of the LED was
flush or below the height of the compartment to protect the LEDs when the heat sink was
repositioned. This was completed using a screw, washer, and spring to facilitate the
perpendicular movement.

a)

b)

c)

Figure 14: (a) Top, (b) bottom and (c) side view of the otoscope

The mounted heat sink was designed to move perpendicular to the otoscope’s frame
using a spring locking mechanism as seen in Figure 15 and 16. The washer was positioned with
its curvature facing the hear sink to eliminate friction between the heat sink and the frame. The
spring assembly was mounted to the base of the frame for structural and ergonomic stability.
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Figure 15: Spring locking mechanism implemented on the heat sink.

a)

b)

c)

Figure 16: Four color LED (a) and single color UV LED (b) used for fluorescence imaging and
illumination. Pictured on the otoscope (c)

2.1.1.3. Filter wheel
The filter wheel in Figure 17 was designed for the use of two 12.5 mm individual filters
during the diagnostic procedure. A single filter compartment was left empty to provide a
traditional otoscopic exam. A 12.5 mm PVC ring was inserted over the filter to prevent
movement and to provide stability.
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Figure 17: CAD drawing of the three-hole filter wheel (units in millimeters) [21]

Figure 18: Three-hole filter wheel pictured on the otoscope frame

2.1.1.4. Camera
The Thorlabs DCC1645C CMOS camera seen in Figure 19 was incorporated to capture
high resolution fluorescence and illumination images of the tympanic membrane. The camera
features a 1.88 in. x1.68 in. x 1.00 in. frame with a ¼ - 20 tap on the bottom of the camera as
seen in Figure 21. The ¼ - 20 tap was used to mount the camera to the otoscope frame and allow
the user to define the position of the camera along the axis. The camera had a frame rate of 25
fps and resolution of 1280 x 1024 pixels. [22] It was USB compatible for visual representation on
a laptop.
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a)

b)

c)

d)

Figure 19: (a) Front (b) side (c) bottom and (d) 3-dimensional Thorlabs CMOS DC1645C dimensions

[22]

Camera

Figure 20: Thorlabs CMOS DCC1645C high-resolution camera used in the design

2.1.2. Electrical Design
The electrical design featured the combination of high power LEDs and circuitry to
illuminate the tympanic membrane. The combination of high power LEDs and LED driver
constant current source was incorporated to input 95-250 VAC and output 4-12 VDC for high
power excitation wavelengths.
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2.1.2.1. Light Emitting Diodes
The high power Red, Green, Blue, white (625 nm, 523 nm, 455 nm, white) and high power
Ultraviolet (400-405nm) LED in Figure 21 were integrated into the design for maximum
efficiency, where the LZ4-00MD00 high luminous efficacy LED featured a 625 nm, 523 nm,
455 nm and 5500K white LED.

a)

b)

Figure 21: (a) LZ4-00MD00 High Luminous Efficacy RGBW LED Emitter and (b) LZ1-00UA00 High Efficacy

Violet LED Emitter by LED Engin [23,24]

Table 1 displays the maximum forward current of 700 mA and the forward voltage which varied
between 2.2 and 3.35 V for each wavelength.
Table 1: Forward Voltage and Current for the RGBW LED

Wavelength
625
523
455
5500K White
Power Rating: 10W

Forward Voltage (V)
2.2
3.35
3.2
3.2
95 Degree Viewing Angle

[23]

Forward Current (mA)
700
700
700
700

The LZ1-000A00 high efficacy UV LED featured a 400-405 nm wavelength. The forward
current was 700 mA and the maximum forward voltage was 3.9V as seen in Table 2. The LED
was set at an 85 degree viewing angle and the LED specifications can be seen in Table 2.
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Table 2: Forward Voltage and Current for the UV LED

Wavelength
Forward Voltage
Forward Current
Power Rating
Viewing Angle

[24]

400-405nm
3.9V
700mA
5W
85

2.1.2.2. LED Driver
The constant current source utilized in this design was the 3 Watt Magtech 20-4169
Constant Current LED Driver. The LED driver featured a 95-250 VAC Input and 4-12 VDC
output and it was rated for 700 mA current output and 1-3 Watts Output Power.

Figure 22: MagTECH 20-4169 constant current source

[25]

2.1.2.3. Switch
Five two pole SPST on-off push button switches as pictured in Figure 23 were used to
maneuver between wavelengths. They were rated for 3A/125 VAC and each of the switches
were mounted into the switch box for easy activation.
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Figure 23: 103-1422-EVX SPST on-off switch

[26]

2.1.2.4. Switch Box
A plastic enclosure was modified to mount five push button switches as in Figure 24. The
power switch that was used to turn the power on and off was also mounted onto the plastic
enclosure.

Figure 24: Plastic LED switch box and enclosure
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Figure 25: CAD drawing of the plastic LED switch box and enclosure (units in inches)

2.1.2.5. Circuitry
The electrical portion of the device was designed to transmit power from an AC power
source as seen in Figure 26. The LED driver constant current source was incorporated to input
95-250 VAC and output 4-12 VDC. A 700 mA constant current rating was determined to be
ideal for the LEDs. The constant current source was wired to the five SPST on-off switches. The
on-off pushbutton switches were connected to a six-pin mating plug and conductor cable. The
six-pin mating plug receptacle allowed current to transfer from the SPST switches to each LED.
The high power LEDs were wired according to the wiring detail provided by the manufacturer as
noted in Tables 3 and 4. Each of the nine pads associated with the high power RGBW LED
functioned as the anode or cathode for a given wavelength as noted in Figure 27.
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Table 3: Pin out of the RGBW LED

Pad
1
2
3
4
5
6
7
8
9

[23]

Die
A
A
B
B
C
C
D
D
n/a

Color
White
White
Red
Red
Green
Green
Blue
Blue
n/a

Table 4: Pin Out for LZ1-00UA00 High Power LED

Pad
1
2
3
4
5

Function
Anode
Cathode
Anode
Cathode
Anode
Cathode
Anode
Cathode
Thermal
[24]

Function
Cathode
Anode
Anode
Cathode
Thermal

Figure 26: Plastic LED Thermal heat sink pad layout

[24]
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Figure 27: LZ1-00UA00 thermal pad distribution as seen in the manufacturer Data Sheet

3

blue

5

green

7

red

1

white
1

D1-A
White

D1-B
Red
D1-C
Green
D1-D
Blue

D2
UV

[24]

Blue
Green
Red
White

brown
black

UV
Power

Current
Source

2

Wall Plug

8
6-Pin
Receptacle

6
4

Switch Box with
Current Source

6-Pin Mating Plug &
6-Conductor Cable

2
Wire Enclosure

Figure 28: Electrical design of the otoscope including the LEDs, switches, mating conductor, constant current
source and power source

2.2. Calibration
Reflectance measurements were collected using a USB4000 spectrometer from Ocean
Optics. The wavelengths of the spectrometer were calibrated using a Mercury Argon Calibration
Source to ensure accurate wavelengths during the spectral and medical imaging components of
the procedure. The wavelength of the spectrometer was calibrated by determining the
coefficients for a third order regression. The predicted wavelength was determined by algebraic
manipulation of the experimental wavelength. The predicted and actual wavelengths in table 5
were determined to calculate the calibration coefficients for the regression of the form
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λρ=I + C1ρ+C2ρ2+C3ρ3,

(1)

.
where λ is the wavelength of the pixel, p, I is the wavelength of pixel 0, C1 is the first calibration
coefficient in (nm/pixel), C2 is the second calibration coefficient in (nm/pixel2), and C3 is the
third calibration coefficient in (nm/pixel3). [27]
Table 5: Spectrometer Calibration Regression Data

True Wavelength
(nm)
365.09
404.36
407.54
435.43
491.4
546.26
577.47
593.36
625.88
696.2
706.43
726.95
729.81
738
749.95
763.35
771.99
794.56
800.68
811.2
826.44
842.3
852.09
871.7
912.63
922.77
965.84

Pixel
#
91
276
290
424
690
958
1108
1190
1354
1713
1766
1873
1888
1931
1994
2064
2111
2232
2264
2322
2404
2492
2546
2655
2885
2944
3194

Pixel #
^2
8281
76176
84100
179776
476100
917764
1227664
1416100
1833316
2934369
3118756
3508129
3564544
3728761
3976036
4260096
4456321
4981824
5125696
5391684
5779216
6210064
6482116
7049025
8323225
8667136
10201636

Pixel #^3
753571
21024576
24389000
76225024
328509000
879217912
1360251712
1685159000
2482309864
5026574097
5507723096
6570725617
6729859072
7200237491
7928215784
8792838144
9407293631
11119431168
11604575744
12519490248
13893235264
15475479488
16503467336
18715161375
24012504125
25516048384
32584025384

Predicted Wavelength
364.944564
404.4668686
407.4405272
435.7786166
491.3561655
546.4210355
576.8234751
593.3146516
626.0201744
696.2991784
706.5189304
727.0271654
729.888814
738.073936
750.0169857
763.2182081
772.0410044
794.6027855
800.5326509
811.2409539
826.2927881
842.3311876
852.1137052
871.7216517
912.4825553
922.8028695
965.9085512

Difference
0.145436039
0.106868638
0.099472759
0.348616648
0.04383449
0.161035476
0.646524879
0.045348425
0.140174354
0.099178441
0.088930355
0.077165394
0.078814004
0.073936016
0.066985665
0.131791897
0.05100443
0.04278546
0.147349074
0.040953944
0.147211899
0.031187588
0.023705238
0.021651736
0.147444667
0.032869513
0.068551229

The intercepts for the linear regression were calculated in Table 6.
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Table 6: Experimental calculation of the calibration regression coefficients

345.3503
0.215872
-6E-06
-2.3E-10

Intercept
X Variable 1
X Variable 2
X Variable 3

The regression was performed after determining the difference between the true wavelength and
predicted wavelength. Table 7 summarizes the r square values for the regression.

Table 7: Regression Statistics

Multiple R

0.999999491

R Square

0.999998983

Adjusted R Square

0.99999885

Standard Error

0.182709533

Observations
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Table 8: Experimental calculation of the calibration regression statistics

Df
3
23
26

Regression
Residual
Total

SS
754700.3946
0.767803787
754701.1624

MS
251566.7982
0.033382773

F
7535826.8

Significance F
4.8143E-69

Table 9: Experimental calculation of the calibration regression statistics

Intercept
X1
X2
X3

Coefficients

Standard
Error

P-value

Lower
95%

Upper
95%

Lower
95.0%

Upper
95.0%

345.3502937
0.215872347
-6.0309E-06
-2.27504E-10

0.157994463
0.000430991
3.00212E-07
5.93957E-11

1.2E-62
6.1E-48
4.4E-16
0.00086

345.02346
0.2149808
-6.652E-06
-3.504E-10

345.6771
0.216764
-5.4E-06
-1E-10

345.0235
0.214981
-6.7E-06
-3.5E-10

345.68
0.2168
-5E-06
-1E-10

The reflectance probe and spectrometer in Figure 32 were calibrated before reflectance
measurements were taken for each patient using the following procedure. The probe was placed
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in a dark environment and a dark and light spectrum were taken as demonstrated by Ocean
Optics every time SpectraSuite was opened, (Figures 30 and 31). The calibration process was as
follows:
1. The calibration process was performed after all spectroscopy equipment was connected to
the computer.
2. Run Spectrasuite.
3. Place the probe (Figure 34) in a dark environment and collect the dark spectrum. The
dark spectrum was collected by clicking on the dark spectrum option on the tool bar.
4. Light source was turned on.
5. Reflection calibration environment was set up appropriately.
a. A reflectance tool (Figure 31) was placed inside of a dark environment. The probe
was placed inside of the dark environment and the light source was turned on. A
light spectrum was collected at this time.

Figure 29: Reflectance source used for calibration

b. The light spectrum was collected by clicking on the light calibration option on the
tool bar.
6. The reflectance option on the tool bar was chosen once the calibration measurements
were completed.
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Figure 30: Light Calibration using Spectra Suite
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Figure 31: Dark Calibration using Spectra Suite.
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a)

b)

Figure 32: (a) Ocean Optics spectrometer and (b) reflectance probe

2.3. Clinical Testing
The following procedure was written according to the Connecticut Children’s Medical
Center’s protocol approved by the Institutional Review Board for the study numbered 09-113.
Patients that participated in this study were recruited for myringotomy and PE tube placement for
standard treatment of recurrent otitis media or persistent middle ear effusion. [28] Digital images
and spectra were recorded during the initial examination regardless of whether an effusion was
present. Patients that had no effusion at the time of surgery had spectroscopy and digital images
recorded and served as the “non-effusion normals” for the study. Patients that were determined
to have a normal otoscopy with a white light otoscope at the time of surgery served as the control
group since there was no available information for spectral or imaging analysis. [28] Patient
information was removed from the results and were retained for further subsequent studies.
Study duration depended on timing of specimen collection, lasted approximately one year. [28]
The procedure began with the removal of debris and cerumen from the ear canal to
improve the visual clearance of the tympanic using the test set-up in Figure 33. A spectral signal
was recorded with a reflectance probe once in the canal and tympanic membrane. A total of four
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reflectance spectra were recorded for each patient. The four reflectance spectra included a canal
and tympanic membrane spectra for the right and left ear for each patient. The spectral
examination took approximately one minute and involved illuminating the auditory canal with a
UV-Visual Xenon Px-2 light source and reflectance probe. The spectral output of the Xenon
light source can be seen in Figure 33. Wavelengths between 200 nm and 800 nm were
illuminated by the emitted by the light source. The resulting spectra ranged between 300 nm and
700 nm and was recorded by SpectraSuite over several seconds.

Figure 33: Experimental spectroscopy set-up

A sample of middle ear fluid was suction removed from patients with an observed effusion after
the myringotomy incisions had been made. [28] The spectral output as a function of wavelength
for the Xenon Px-2 uv-visual light source, as pictured in Figure 34, verified that wavelengths
between 200 nm and 800 nm illuminated the tympanic membrane.
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Figure 34: Spectral Output of the PX-2 UV-Visual Light Source

[29]

Five excitation and illumination wavelengths were studied for fluorescence imaging
including: white light, 385-420 nm, 450-470 nm, 520-535 nm and 640-650 nm. Each of the
chosen wavelengths were emitted into the ear canal and tympanic membrane as in a typical
otoscopic examination. A 425 nm and 500 nm filter were used to attenuate the excitation
wavelengths. The emission wavelength passed through a CMOS camera and an image was
recorded of the tympanic membrane. Fluorescence and illumination images of the tympanic
membrane were recorded and compared for “effusion” and “non-effusion” patients. This was
done for each wavelength and prolonged the surgery an additional three to five minutes. There
was no additional associated risk to the patient. [28]
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3.0 Results
The results include two separate sets of data: design validation and clinical trials. The
design validation was performed to ensure appropriate functionality of the otoscope before
clinical trials. The validation procedure required that the device be tested on one individual with
no signs of otitis media. A normal tympanic membrane was imaged at each wavelength and the
initial benefits of the newly designed otoscope in comparison to a traditional otoscopy were
identified.
The clinical trials were defined as an experimental procedure attached to a routine
myringotomy and PE tube placement procedure. Here, the newly designed otoscope was used in
a routine surgical procedure and not in a controlled setting.

3.1. Design Validation
The newly developed otoscope was tested before clinical trials to compare differences
between a normal tympanic membrane with various wavelengths, in order to establish a normal
control group prior to recruiting patients. This served as the device validation. The wavelengths
chosen for the procedure were a 625 nm, 523 nm, 455 nm, 5500 K and their LEDs were located
on a heat sink for thermal stability and conductivity. Figure 35 graphically represented the power
spectrum and bandwidth for each wavelength.
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a)

b)

Figure 35: Relative Spectral Power vs. Wavelength for the (a) 4 color LED and (b) Single Color UV LED [23,24]

The images below were captured with a high resolution CMOS camera when the LEDs
were tested in a normal tympanic membrane with a 450 nm and 500 nm longpass filter. These
filters captured the emission wavelengths that originated at wavelengths longer than 450nm and
500 nm, respectively (Figure 36). Preliminary results were recorded as a standard for a normal
tympanic membrane to ensure accuracy of the device before patients were recorded for the study.
Additionally, the preliminary image presented the reflectance of keratin, cerumen, and bone in
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the tympanic membrane with well defined blood vessels and contrast between the malleus and
the rest of the tympanic membrane. [8]

a)

b)

Figure 36: Longpass (a) 450nm and (b) 500nm filter [30,31]

The images presented below focused on a clear transparent tympanic membrane that
centered on the malleus bone with high contrast. The ear showed no signs of otitis media and
was considered normal in all diagnostic aspects. It was proposed that the excitation wavelengths
aided in the determination of an effusion behind the tympanic membrane regardless of the
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tympanic membrane thickness. Therefore, the excitation wavelengths would potentially penetrate
the tympanic membrane with enough power that structures and effusions behind it would
fluoresce. The detection of an effusion allowed for a highly accurate diagnosis of otitis media
and provided a proof of concept of the otoscope design. Further fluorescence and reflectance
measurements may provide additional bacterial properties as well.
An image was recorded for a normal tympanic membrane with the 5500K white LED
pictured in Figure 37. The white LED was determined to enhance the presence of vascularity and
contrast of the malleus bone. The white light was also determined to provide increased contrast,
magnification, and resolution in comparison with a traditional otoscopic visual representation as
seen in Figure 37.
Malleus

Figure 37: Tympanic membrane using white light

Blue and ultra-violet wavelengths were investigated to excite photons in the tympanic
membrane. Images that were recorded for emission wavelengths between 425 nm and
approximately 1000 nm were passed using a 425 nm and 500 nm longpass filter for 400 nm
through 405 nm and 455 nm excitation sources. It was hypothesized that this wavelength will
show wax, bacteria, and keratin fluorescence in the ear based on the preliminary images. Figure
38 displays an image of a normal tympanic membrane using a 455 nm blue LED.
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Figure 38: Tympanic membrane using blue light

The 523 nm LED was incorporated into the design to obtain illumination images. The
chosen LED spectrum ranged from 475 nm to approximately 590 nm with a dominant
wavelength at 523 nm. It was proposed that this wavelength will show wax, keratin, and
fluorescence of the effusion located behind the tympanic membrane with enhanced resolution
and contrast of the middle ear region based on the preliminary results. Figure 39 displays an
image of a normal tympanic membrane recorded using the 523 nm light source.

Figure 39: Tympanic membrane using green light

The 625 nm LED in Figure 40 was incorporated into the design for illumination of the
tympanic membrane. Regions that absorb light may appear darker in specific areas of interest but
fluorescence is not expected due to the wavelength. There were differences in light intensity in
comparison to a normal ear when the 625 nm LED was illuminated in an ear with otitis media.
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Enhanced contrast
between malleus and
tympanic membrane

Figure 40: Tympanic membrane using 645nm light

The preliminary image results showed the reflectance of keratin, cerumen, and bone in the
tympanic membrane and well-defined blood vessels and contrast between the malleus and the
rest of the tympanic membrane were observed.

3.2. Signal Processing
Signal processing developed by Trinity College enhanced the contrast of the malleus and
the tympanic membrane for better identification of structures. The signal processing techniques
were applied to isolate various regions of the tympanic membrane using MatLAB to increase the
resolution of the anatomical and physiological properties of the tympanic membrane. The signal
processing techniques were investigated to compare the recorded images and spectra for each
patient.
The signal processing algorithms implemented for each of the images were capable of
removing an artifact by isolating specific regions of the tympanic membrane and subtracting the
artifact of interest. Additionally, an algorithm capable of enhancing the images was used to
increase the contrast and definition of the identified structures. [8] Figure 41 displayed an example
of an enhanced white light image of the tympanic membrane.
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Figure 41: Enhanced white light image using signal processing algorithms [8]

3.3. Effusion Spectra
Fourteen of the 22 ears were determined to have otitis media with effusion due to the
presence of fluid in the middle ear region. The patient descriptions and the classification of
effusion spectra for each patient were displayed in Tables 10 and 11. Each of the spectra were
classified according to percent reflection as a function of wavelength as defined in the Methods
and Table 11. Tympanic membrane spectra were characterized by a gradual decreasing slope
between 560 nm and 800 nm, while the canal spectra were characterized by rapid increase in
percent reflection between 575 nm and 750 nm.
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Table 10: Experimental Observations and Patient Descriptions

Date
09/25/13
09/25/13
09/25/13
09/25/13
09/25/13
09/25/13
10/09/13
10/09/13
10/16/13

Patient
P1
P1
P2
P2
P3
P3
P1
P1
P2

Ear
Right
Left
Right
Left
Right
Left
Right
Left
Right

Description
Thin pus
Thin pus
No fluid
No fluid
Thick fluid
Thin Fluid
Thin Fluid
No Fluid
No Fluid

10/16/13

P2

Left

No Fluid

10/30/13
10/30/13
11/06/13
11/06/13
11/13/13

P1
P1
P2
P2
P1

Right
Left
Right
Left
Right

No Fluid
No Fluid
Thick purulent fluid
Thin Fluid
Thick mucoid fluid

11/13/13

P1

Left

Thick mucoid fluid

11/13/13
11/13/13
12/04/13
12/04/13
01/08/14
01/08/14

P2
P2
P1
P1
P1
P1

Right
Left
Right
Left
Right
Left

Fluid
Fluid
Purulent fluid
No Fluid
Thick Fluid
Thick pus

Additional Comments
Moderate vascularity
Thick TM
Normal vascularity
Normal vascularity
Moderate vascularity
Retracted ear drum
Moderate vascularity
Normal vascularity
Myringosclerosis, Thin TM, Normal
vascularity
Thin TM, retracted thin TM, high
vascularity
NA
NA
NA
NA
Moderate vascularity in the TM.
Some vascularity in the canal
Moderate vascularity in the TM.
Some vascularity in the canal
NA
NA
Thick TM and high vascularity
Myringosclerosis
Moderate-high vascularity
Moderate vascularity
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Table 11: Experimental effusion classification for each patient

Non Effusion Normal Spectra Classification
Subject/Ear

Effusion
Consistency

TM Class

Canal Class

9-25-13 P1 L
9-25-13 P1 R
9-25-13 P3 L
9-25-13 P3 R
10-09-13 P1 R
11-06-13 P2 L
11-06-13 P2 R
11-13-13 P1 L
11-13-13 P1 R
11-13-13 P2 L
11-13-13 P2 R
12-04-13-P1 R
01-08-14 P1 L
01-08-14 P1 R

Thin
Thin
Thin
Thick
Thin
Thin
Thick
Thick
Thick
Thin
Thin
Thick
Thick
Thick

2
2
2
2
2
3
3
1
1
2
2
1
1
1

2
2
2
2
3
4
1
1
1
4
4
1
1
1

3.3.1. Tympanic Membrane
There were two predominant spectral trends determined for the tympanic membrane effusion
spectra that were characterized by percent reflection as a function of wavelength and effusion
consistency as seen in Figures 42 through 45. Tympanic membrane spectral waveforms were
determined to be consistent with the thin and thick spectra trends .
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Figure 42: Tympanic membrane reflectance spectra for patients with an effusion at the time of surgery

Class one tympanic membrane effusion spectra resulted in the following waveform and was
predominatly characterized by thick effusion consistency. The initial peak at 550 nm can be
attributed to hemoglobin and is present in all tympanic membrane spectra. The tympanic
membrane spectra varied between 30 and 110 percent reflection.
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Figure 43: Class 1 Tympanic Membrane Thick Effusion Spectra
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The second class of TM effusion spectra was characterized by thin fluid and a rapid increase
in percent reflection between 575 nm and 650 nm and a rapid decrease in percent reflection
between 650 nm and 750 nm. Percent reflection varied between 50 and 225 percent. The initial
peak occurred at 555 nm, which was also attributed to hemoglobin.
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Figure 44: Class Two Tympanic Membrane thin effusion spectra

Class three tympanic membrane effusion spectra were determined to be inconsistent with the
thick and thin effusion consistency spectra. Percent reflection varied between 35 and 50 percent.
The characteristic peak at 550 nm due to the presence of hemoglobin was present in both
reflectance spectra.
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Figure 45: Class three tympanic membrane reflectance spectra inconsistent with effusion and non effusion
classifications

3.3.2. Canal Spectra
The two dominant tympanic membrane spectra classifications were also used to classify
the canal spectra. The spectra were classified according to the tympanic membrane effusion
consistency to determine whether there was a correlation between the canal and tympanic
membrane spectra for effusions with specific consistencies. The fluid was located behind the
tympanic membrane and no fluid was present in the canal. Canal spectra for ears with a
predominantly thick effusion were categorized into the predetermined Class one spectra. They
were similar in waveform to Class one TM effusion spectra with a higher percent reflection. The
same was identified for the Class two canal effusion spectra in respect to thin effusion
consistency. Class three and four effusion canal spectra were characterized by unique waveforms
potentially due to the medical condition or disturbance. It was determined that most of the canal
spectra shapes were similar to their tympanic membrane effusion spectra shapes. All of the canal
reflectance effusion spectra can be seen in the following plot.
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Figure 46: All canal reflectance spectra with an effusion

The canal reflectance spectra were categorized in terms of the spectral waveform in
Figures 46 through 50. The first classification of canal spectra shape was dominated by the same
shape as tympanic membrane spectra for effusions with thick consistency and a decreasing slope
between 600 nm and 850 nm. All of the spectra had a percent reflection under 350 percent.
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Figure 47: Class one canal reflectance spectra for ears with a thick effusion
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The second class of canal effusion spectra was characterized by the same shape as tympanic
membrane spectra for thin effusion consistency. This class was characterized by rapid increase in
percent reflection between 575 nm and 650 nm and a rapid decrease in percent reflection
between 650 nm and 750 nm.
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Figure 48: Class two canal reflectance spectra for ears with a thin effusion

The third class of canal spectra was determined because it did not follow the same waveform as
the thick and thin spectra. This spectrum may be attributed to a disturbance of the probe during
the procedure. The fourth classification of canal spectra for ears with an effusion resulted in a
curve that combined characteristics of Class one and Class two waveforms. The characteristic
hemoglobin spike was also present in these spectra.
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Figure 49: Class three canal reflectance spectra for ears with a thin effusion
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Figure 50: Class four canal reflectance spectra for ears with an effusion

3.3.3. Effusion Statistics
A chi square distribution was performed to determine the goodness of fit between the
number of effusions that were observed as having class one or two effusion spectra and the
number of effusions that were expected to have class one or two effusion spectra. Table 12
displays the expected and observed values for each of the dominant effusion classifications for
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the tympanic membrane characterized by thick and thin fluid, respectively. The chi square was
determined using equation 2. [33]

(2)
The degrees of freedom, n-1, where n is the number of classifications was determined to be 1.
The chi square value was determined to be 0.2917 where p= 0.7. Therefore, p>0.05 and
insignificant. It was determined that there was no statistical difference between the number of
observed and expected fluid consistencies based on this test. The chi square distribution was only
determined for tympanic membrane spectra since there was no effusion in the canal. It was
however, determined that the canal effusion spectra followed the same classifications as the
tympanic membrane.
Table 12: Chi Square Values

Observed
Expected
Total
Chi Square

Class 1
5
6
11

Class 2
9
8
17

Total
14
14
28
0.291667

3.4. Noneffusion Spectra
The TM and canal noneffusion results were also characterized into the predetermined Class
one and two spectra as seen in Table 13. There was no effusion present in the canal, however the
classifications followed waveforms similar to the tympanic membrane and canal.
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Table 13: Non Effusion Normal Spectra Classification

Non Effusion Normal Spectra Classification

Subject/Ear

TM Class
2
2
2
1
1
1
1
1

9-25-13 P2 L
9-25-13 P2 R
10-9-13 P1 L
10-16-13 P2 L
10-16-13 P2 R
10-30-13 P1 L
10-30-13 P1 R
12-04-13 P1 L

Canal Class
2
2
2
1
1
1
1
1

3.4.1. Tympanic Membrane
Percent reflection was determined to be between 30 and 50 percent for the first
classification of tympanic membrane spectra with no effusion. There was a gradual decrease or

Percent Reflection

no variance in percent reflection. The characteristic peak at 550 nm was present in all patients.
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Figure 51: Class one tympanic membrane spectra in the presence of no effusion
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Class two noneffusion spectra were characterized by a rapid increase in percent reflection
between 600 nm and 620 nm and rapid decrease in percent reflection between 620 nm and 750
nm as in Figure 52. A peak at 550 nm was present in these spectra due to hemoglobin.
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Figure 52: Class two tympanic membrane spectra in the presence of no effusion

3.4.2. Canal Spectra
Four ears were characterized by a decreasing slope between 600 nm and 800 nm for the
first classification of canal spectra with no fluid retention in Figure 53. A characteristic
hemoglobin peak around 600 nm was also present.
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Figure 53: Class one canal spectra in the presence of no effusion

The second class of canal spectra for ear with no fluid retention was displayed in Figure 54. The
spectra was characterized by an increase in percent reflection between 520 nm and 620 nm.
There was also a decrease in percent reflection between 620 nm and 750 nm. A spike in percent
reflection was not expected due to the absence of fluid in this region. The disruption of the
spectra between 525 nm and 600 nm may be attributed to a disturbance during the procedure.
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Figure 54: Class two canal spectra in the presence of no effusion

The third class of canal spectra in the presence of no effusion was displayed in Figure 55. Extra
spikes between 525 nm and 625 nm may be attributed to a physical disruption during the
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reading.
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Figure 55: Class three canal spectra in the presence of no effusion
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Similarities between fluid consistencies were determined from this study. There were also
trends between the waveforms of TM and canal spectra for patients with an effusion and no
effusion with a couple deviations. This finding may lead to further investigation to determine
whether the bacteria causing otitis media has characteristic spectral properties. The images were
enhanced through signal processing to improve resolution and contrast in the middle ear region.

3.5. Digital Imaging
Images were recorded by a Thorlabs camera for each patient. A white, white-blue, blue,
green, red, and uv-visual images were recorded. A 500 nm filter was applied to the blue
wavelength and an image was recorded. An image of a 425 nm and 500 nm filter with the UV
wavelength was also recorded for each patient. Figures 58 through 62 displayed some of the
images recorded for 12-04-14 P1 R. An effusion and swollen tympanic membrane were
observed. Figure 56 was recorded with a white-blue excitation source. The original image can
be seen in the upper left corner of the image. Signal processing algorithms were used to enhance
the characteristics of the image. Blue and green wavelengths had the same effect.
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Well defined
vascularity

Figure 56: Tympanic membrane image recorded using White and blue wavelengths.

The UV light source was emitted into the ear and Figure 57 was recorded without a filter.
Enhanced contrast and vascularity resulted from this wavelength.
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Figure 57: Tympanic membrane image recorded using a UV 405nm wavelength.

The UV light source and a 425 nm filter were emitted into the ear and Figure 58 was recorded.
Blue Fluorescence was observed an enhanced through signal processing.

Blue fluorescence

Figure 58: Tympanic membrane image recorded using a UV 405nm wavelength and 425nm filter.
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The UV light source and a 500 nm filter emitted into the ear and Figure 59 was recorded.
Cerumen and green fluorescence was observed.
Green fluorescence

Figure 59: Tympanic membrane image recorded using a UV 405 nm wavelength and 500 nm filter

The red light source was emitted into the ear and Figure 60 was recorded. This wavelength
provided contour observations not observed with the other wavelengths.
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Figure 60: Tympanic membrane image recorded using a red wavelength

The results show that there is no obvious difference between images with and without an
effusion. Figure 61a is an image of the tympanic membrane using blue and white light in the
presence of an effusion. Figure 61b is an image of the tympanic membrane with no effusion.
Enhanced resolution and magnification are observed in both.

a)

b)

Figure 61: (a) Tympanic membrane image recorded using blue and white light in the presence of an effusion. (b)
Tympanic membrane image recorded using blue and white light in the absence of an effusion

58

It was also determined that the presence and absence of an effusion each resulted in the
observation of fluorescence as seen in Figure 62a and 62b.

a)

b)

Figure 62: (a) Tympanic membrane image recorded using a 405nm excitation source and 425nm longpass
filter in the presence of an effusion. (b) Tympanic membrane image recorded in the absence of an effusion

4.0 Discussion
This study investigated the novel design of a device that utilized spectroscopy and
fluorescence imaging to provide physicians with a tool to present a unique representation of the
middle ear to enhance an infection’s characteristics. The design, along with medical imaging and
spectroscopy has shown to be an effective approach to diagnose otitis media with increased
diagnostic certainty. Various factors that typically led to the inaccurate diagnosis of otitis media
by a general practitioner and otolaryngologist due to the difficulty of differentiating between the
various types of otitis media were considered.
Acute otitis media is a condition that is characterized by inflammation of the middle ear in
the presence of an infected effusion and was typically diagnosed after an upper respiratory
infection or fever. General practitioners diagnose a red, swollen tympanic membrane with acute
otitis media without further investigation; however, more information is required to confirm the
diagnosis. A whiteish-yellow swollen tympanic membrane was generally the observation of
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acute otitis media due to the presence of pus behind the tympanic membrane. Furthermore, otitis
media with effusion was resistant to antibiotics and was characterized by a non-infected effusion.
It was important that a highly accurate approach was applied when a diagnosis is made because
not all classifications of otitis media were receptive to antibiotics.
Currently the Welch Allen otoscope is commercially available to induce movement within
the tympanic membrane through an insufflation port. Activation of the insufflation port was a
potential benefit to many modern day otoscopes due to its capabilities. Specifically, an effusion
was present in the middle ear region if there was no movement of the tympanic membrane when
air was forced through the port into the ear. The tympanic membrane movement, in addition to
the expertise of a specialist, was one of the most efficient mechanisms to determine an accurate
diagnosis without intraoperative care to date.
The otoscope was designed to build off of traditional otoscope components to provide a
comfortable, easy to use device. The design incorporated a unique combination of fluorescence
and illumination components as well as a traditional otoscope head and basic aluminum
structure. The Welch Allen head incorporated into this design is widely used by practitioners and
otolaryngologists to efficiently emit light into the tympanic membrane. A new otoscope head
was not included in the design because of the simplicity of the structure and the time allotted for
the project. The otoscope head contained a light pipe, magnifying lens, and additional
magnification and focus settings to view the tympanic membrane.
The device design incorporated components that are not traditionally featured on
commercial otoscopes. Traditional otoscopes primarily rely on white light and a physician’s
trained eye to determine whether there was presence of otitis media and an effusion. The new
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design incorporated five different wavelengths across the spectrum that had unique individual
characteristics to enhance the reliability of an accurate diagnosis. Specifically, the UV, blue, and
combination of UV and Blue light served to enhance the internal anatomy around the tympanic
membrane as in Figure 63. The combination of blue and green also enhanced the tympanic
membrane with better visibility for certain patients. Figure 63 was not processed through the
signal processing algorithm.

Figure 63: Tympanic membrane image recorded using a white and blue combination light source

Contrast between the malleus and the rest of the tympanic membrane was observed with
these wavelengths in normal patients. Enhanced definition of the swollen tympanic membrane
and vascularity were observed in patients with otitis media. The surgeon was also capable of
determining whether or not an effusion was present from the medical images. The characteristics
in the presence and absence of an effusion were not obvious; however, a physician was able to
determine whether or not the fluid was present from the images. Furthermore, the results showed
that additional research is necessary accurately determine what is responsible for fluorescence
the middle ear region. Fluorescence was observed in the presence and absence of an effusion
potentially due to fluid or the anatomical characteristics of the tympanic membrane. Conditions
such as myringosclerosis, a condition that is characterized by calcium deposits and dense
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connective tissue due to persistent acute otitis media, were also enhanced with each wavelength.
myringosclerosis typically resulted in a thicker nontransparent tympanic membrane due to the
collection of cells on the surface. The ultraviolet and white/blue combination wavelengths
enhanced these features as pictured in Figure 64.

a)

Bleb

b)

Figure 64: (a) Ultraviolet and (b) white/blue combination image of myringosclerosis before signal processing

Fluorescence spectroscopy is the study of the interaction of electrons with a photon or
other type of electromagnetic radiation. A high-energy photon is absorbed during the
fluorescence process and results in the promotion of an electron to an excited, higher energy,
vibrational state as in Figure 65. The electron energy is subsequently transferred to a lower
vibration state and relaxed back to ground state with lower energy. A longer wavelength of light
is emitted as a result of the process. The emitted color of fluorescence light is dependent on the
vibrational states that the electron is promoted to. [32] Blue and Ultraviolet wavelengths were
investigated as part of this study and found to enhance characteristics of otitis media, where blue
and green fluorescence were detected.
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Figure 65: Fluorescence energy level diagram

[32]

Fluorescence was observed from the UV and Blue wavelengths using a 425 nm and 500
nm filter. Excitation wavelengths were emitted into the ear canal using the otoscope speculum.
The excitation light reached the tympanic membrane and was reflected back into the otoscope
with the corresponding longer emission wavelength. The excitation wavelength was filtered out
and the emission wavelength was allowed to pass for observation as demonstrated in the Figure
66.
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Emitted light enters the ear canal through
the speculum (405 nm and 450 nm)

The excitation wavelength reaches
the tympanic membrane

The excitation wavelength is
reflected along with the emission
wavelength back into the head of the
otoscope

The excitation wavelength and the
fluorescence emission wavelength
pass through a filter

The excitation wavelength is
attenuated

The emission wavelength is passed

Figure 66: Fluorescence flow chart

The 425 nm longpass filter paired with a 405 nm excitation source resulted in
fluorescence images. Additionally, the 500 nm filter paired with the 405 nm filter also resulted in
fluorescence images. Fluorescence was observed for patients with an effusion and no effusion.
This may lead to the conclusion that all forms of otitis media fluoresce including, acute otitis
media, and otitis media with or without effusion, and chronic otitis media. Further research to
determine the effect of different bacteria species may also help to determine a relationship
between the detection of fluorescence and the type of bacteria causing the infection. Additional
techniques such as optical coherence tomography in addition to fluorescence spectroscopy may
also lead to the determination of biofilms in otitis media mucosa. The determination of the type
of bacteria and response to antibiotics would enable physicians to prescribe antibiotics based on
an accurate bacterial diagnosis instead of visual observation.
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The reflectance spectroscopy procedure resulted in two dominant waveforms between
550 nm and 800 nm. The results for a thin effusion accurately represented the percent reflectance
as a function of wavelength as expected. The tympanic membrane results in the case of an
effusion were represented by a waveform that rapidly increased prior to a rapid decrease in
percent reflection as a function of the associated wavelengths. This was expected due to the
presence of an effusion; however, further research is required to validate the reason. The
tympanic membrane results in the case of a thick effusion were also consistent with the original
hypothesis because there was a gradual decrease in the percent reflectance as a function of
wavelength. Initially, it was hypothesized that the spectra was characteristic of the consistency of
the effusion fluid. A chi square statistical distribution validated that this was a valid observation
for the tympanic membrane spectra.
Two dominant canal classifications were consistent with the two dominant tympanic
membrane classifications. It was originally hypothesized that class one and two waveforms were
characteristic of the effusion consistency; however, there was no effusion present for the canal
spectra that were consistent for these results. This leads to the conclusion that there are other
factors in addition to effusion consistency that influence the reflectance spectra. Factors such as
bacteria identification and individual properties of the tympanic membrane should be considered.
Any additional inconsistencies in the data can be attributed to a variety of factors. The
lights were dimmed during the myringotomy procedure for the spectra and fluorescence imaging
collection. However, additional light from the operating room may have affected the spectra
collection if the reflectance probe was not appropriately directed into the ear canal. Furthermore,
variations in the spectra, as seen in the third class of canal spectra for patients with an effusion,
can be attributed to a disruption of the probe during the procedure. It was possible that the
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reflectance probe may have made contact with an internal structure during the process. Further
inconsistencies may be attributed to the calibration method that was performed each day of data
collection. A dark box was used to collect the dark measurements; however, a better calibration
source may have provided a more efficient mechanism to collect the data.
The 455 nm blue wavelength was also used to detect fluorescence in the tympanic
membrane. This wavelength served as a sufficient excitation source; however, the correct filter
may not have been implemented for each reading. The 500 nm filter and the 455 nm light source
resulted in a combination of fluorescence and faint blue light. The 455 nm excitation source had
a broad bandwidth that interfered with the 500 nm filter. Faint blue light was not attenuated by
the 500 nm filter as a result. A longpass filter capable of attenuating wavelengths below 500 nm
should be considered in the future design for 455 nm excitation wavelengths.
Previous studies suggested that spectroscopy may provide reasonable evidence to suggest
that the reflectance and absorption measurements of clinical data, in combination with other noninvasive devices, aided in diagnosis. [10] Further research and collaborative design could combine
optical coherence tomography and fluorescent spectroscopy for commercial use in a pediatrics
office. Furthermore, the research presented in this paper could be applied to differentiate acute
otitis media and otitis media with effusion diagnosis in pediatric patients. Optical coherence
tomography and the determination of bacteria biofilms may provide the reason that the biofilms
are not susceptible to antibiotics in certain cases. Fluorescence spectroscopy was applied to this
research to determine a comparison between effusion and non-effusion normal otitis media
patients. Reflectance, absorption, and fluorescence spectroscopy combined with medical imaging
during an otoscopic examination may provide insight to whether there is fluid in the middle ear
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region. In addition, the fluorescent characterization of bacteria infected fluid would provide the
correct treatment for the patient.
Antibiotics will continue to be prescribed medication without high diagnosis certainty if a
new diagnostic criterion is not developed. The development of a new device will reduce overdiagnosis of otitis media in the pediatric community and increase the accuracy of a diagnosis by
a general practitioner. An otoscope capable of fluorescence and high resolution imaging would
allow the physician to make an interpretation based off of a detailed image of the tympanic
membrane. Further classification of reflectance spectra would also allow the physician to link the
visual interpretation to a series of data that would assist to make an appropriate diagnosis. An
otoscope that combines the use of spectroscopy and fluorescence imaging would facilitate this
process. A future otoscope would potentially combine a reflectance probe in the handle. The use
of plastic and three dimensional printing would also enhance the design. Furthermore,
fluorescence imaging and reflectance spectroscopy will determine an optimal otoscopic
procedure to determine whether otitis media with effusion is present.
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5.0 Conclusion
The development of a new device for fluorescence imaging and spectroscopy was
investigated to increase the reliability of otitis media diagnosis. Distinct spectral and otoscopic
images of the tympanic membrane were observed using the novel design of an otoscope. The
reflectance spectroscopy portion of the research resulted in a characterization of ears with and
without an effusion present in the middle ear region. Differences in effusion consistency were
also characterized by distinct spectral waveforms between 560 nm and 800 nm using a UVvisual light source. There were trends between the waveforms of the tympanic membrane and
canal spectra for patients with an effusion and no effusion may lead to further investigation to
determine whether the bacteria causing otitis media has characteristic spectral properties.
The varying wavelengths of light emitted from the otoscope also aided in structural
recognition and enhancement in the middle ear region. Specific wavelengths such as the UVvisual 405 nm and 455 nm excitation sources induced fluorescence in the blue and green
spectrum. Fluorescence was detected for patients with an effusion that could potentially lead to
the conclusion that specific bacteria in an effusion can produce fluorescence. The use of
fluorescence imaging to assist the physician could potentially aid in increase of otitis media
diagnostic certainty due to identification of fluorescence in the middle ear region. Further
research is required to determine spectral and digital differences due to the fact that patients with
no effusion also had faint fluorescence readings. The Methods described proved to initiate the
development of criteria to increase the level of diagnostic certainty of otitis media that will
reduce over-diagnosis of otitis media in the future.
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9-25-13 P1 Left
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9-25-2013 P1 Right
Images BGR, BR, BR500, GR, RR, UVR, UVR425, WBR, WR
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9-25-13 P2 Left
Images B500L, BGL, BL, GL, RL, UV425L, UV500L, UVL, WBL, WL
2000
1800
1600

Canal and Tympanic Membrane Reflectance
Spectra September 25, 2013
Patient 2

1400
1200

9-25-13 P2 CANL

1000

9-25-13 P2 CANR

800

9-25-13 P2 TML

600

9-25-13 P2 TMR

400
200
0
450

550

650

750

850

75

76

9-25-2013 P2 Right
Images: BGR, BR, BR500, GR, RR, UVR, UVR425, UVR500, WBR, WR
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9-25-2013 P3 Left
Images: BL,BL500, GL, RL, UVL2, UVL425, UVL500, WBL WL
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9-25-2013 P3 Right
Images BGL, BGR, BR, BR500, GR, RR, UVR, UVR500, WBR, WR
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10-9- 2013 P1 Left
Images: B500L, GBL, BL, GL, RL, UV425L, UV500L, UVL, WBL, WL
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10-9-2013 P1 Right
Images: 2BR, BGR, BR, BR500, BR5002, GR2, RR, UV425R2, UVR, WBR, WBR2, WR2
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10-16-2013 P1 Left
Images: BGL, BL, BL500, GL, RL, UVL, UVL425, UVL500, WBL, WL
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10-16-2013 P1 Right
Images: BR500, BR, GBR,GR, RR, UV500R, UVR, UVR425, WBR, WBR2, WR
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10-16-2013 P2 Left
Images: BGL, BL, BL500, GL, RL, UVL 425, UVL500, UVL, WBL, WLBLEMP
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10-16-2013 P2 Right
Images: BGR, BR, BR500, GR, RR, UVR, UVR425, UVR500, WBR, WR
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10-30-P1 Left
Images: B500L, BGL, BL, GL, RL, UVL, UVL425, UVL500, WBL, WL
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10-30-2013 P1 Right
Images: B500R, BR, GR, RR, UVR, UVR425, UVR500, WBR, WR
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11-06-2013 P2 Left
Images: B500L, BG500, BGL, BL, GL, RL2, UVL, UVL425, UVL500, WBL, WL
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11-06-2013 P2 Right
Images: B500R, BR, GR, RR, UV425R, UV500R, UVR, WBR
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11-13-13 P1 Left
Images: BGL, BL, BL500, GL, RL, UVL, UVL425, UVL500, WBL
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11-13-13 P1 Right
Images: BGR, BR, GR, RR, UV500R, UVR, UVR425, WBR, WR2
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11-13-13 P2 Left
Images: BGL, BL, BL500, UVL425, UVL500, WB2L, WL2
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11-13-13 P2 Right
Images: B500R, BGR, BR, GR, RR2, UVR, UVR425, UVR500, WBR, WR
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12-04-2013 P1 Left
Images: B500L, BGL, BL, GL, RL, UVL, UVL425, UVL500, WBL, WL
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12-04-2013 P1 Right
Images: B500R, BGR, BR, GR, RR, UVR, UVR425, UVR500, WBR, WR

105

1-8-2014 P1 Right
Images: WBR, BR, WR, GR, UV500R, GBR, RR, UVR, UV425R, UV500R2
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1-8-2014 P1 Left
Images:WL, WBL,BL, B500L, BGL, GL, RL, UVL, UV425L, UV500L
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